Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462917 · ClinicalTrials.gov registry record · NA
REVEAL III: Risk Evaluation and Education for Alzheimer's Disease
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
NCT00462917 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 290 participants.
The verdict
NCT00462917, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
Study Summary
The purpose of this study is to provide healthy adults with genetic testing and information about their chances of developing Alzheimer's disease.
Interventions
- BEHAVIORAL Pleiotropic info, in-person disclosure
- BEHAVIORAL AD-only info, in-person disclosure
- BEHAVIORAL Pleiotropic info, phone disclosure
- BEHAVIORAL AD-only info, phone disclosure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00462917
The ClinicalTrials.gov registry entry for NCT00462917 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Pleiotropic info, in-person disclosure is the first listed.
NCT00462917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00462917 about?
NCT00462917 is a clinical study titled "REVEAL III: Risk Evaluation and Education for Alzheimer's Disease". The purpose of this study is to provide healthy adults with genetic testing and information about their chances of developing Alzheimer's disease.
What is the current status of trial NCT00462917?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2007-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00462917?
The interventions under investigation include: Pleiotropic info, in-person disclosure (BEHAVIORAL), AD-only info, in-person disclosure (BEHAVIORAL), Pleiotropic info, phone disclosure (BEHAVIORAL), AD-only info, phone disclosure (BEHAVIORAL).
Who is sponsoring clinical trial NCT00462917?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.